Archives

by in
Entry Author Date Location
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Alder Biopharmaceuticals Receives $38,000,000 Series D Financing Round 04/19/12 Seattle
Calisolar Raises $8M More 02/17/11 San Francisco
Calisolar Pulls In $3M 12/06/10 San Francisco
$15M More for Calisolar 07/16/10 San Francisco
Aquinox Pharma Nabs $25M 06/17/10 Seattle
Calisolar Garners $20,000,000 New Funding Round 02/11/10 San Francisco
Alder Rises From Ashes of Layoffs to Become Seattle Biotech Force 01/04/10 Seattle
Fresco Garners $9,500,000 New Funding 10/08/09 San Diego
Presidio Pharmaceuticals Secures $27,000,000 Series B Financing 07/10/09 San Francisco
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News 06/11/09 Seattle
Ventures West Cashes Out Stake in OncoGenex, Developer of Prostate Cancer Drug 06/10/09 Seattle
Ventures West “Sells High” After Positive Prostate Cancer News From OncoGenex 12/18/08 Seattle
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy 09/18/08 Seattle
Nusym Technology Secures $8,000,000 Series B Financing Round 09/10/08 San Francisco
Celator Raises $22.5 Million For Combination Chemo Drugs 07/29/08 Seattle
Sensys Networks Obtains $5,000,000 New Funding Round 07/25/08 San Francisco
Socializing at WBBA: Tom Ranken’s Surprise, Insilicos Goes In Vivo, and Cleantechs to Watch in the Tri-Cities 07/18/08 Seattle
Alder Biopharmaceuticals Inc. Garners $40,000,000 Series C Financing Round 01/11/08 Seattle
Presidio Pharmaceuticals Obtains $26,000,000 Series B Round 08/29/07 San Francisco
Alder Biopharmaceuticals Inc. Receives $16,000,000 Series B Financing 07/07/06 Seattle
Nusym Technology Obtains $8,100,000 Series B Funding 08/22/05 San Francisco
Alder Biopharmaceuticals Inc. Secures $11,100,000 Series A Round 08/15/05 Seattle
Page 1 of 1